...laboratory to develop molecular diagnostic systems and assays for infectious disease. The lab will use ProGenTech's...
...platform and cassettes to develop diagnostic systems to detect emerging pathogens identified by China CDC. ProGenTech...
...outside of China, and Team On S&T Ltd. (Beijing, China) will have rights in China. ProGenTech Ltd....

...MRSA), methicillin-sensitive S. aureus (MSSA), vancomycin-resistant enterococci (VRE) and Clostridium difficile infection for use on ProGenTech's...
...nucleic acid extraction and purification platforms. Human Genetic will retain IP related to the assays. ProGenTech...
...tests. Financial terms were not disclosed. Human Genetic Signatures Pty. Ltd. , North Ryde, Australia ProGenTech Ltd....

...Research tool supplier ProGenTech (Emeryville, Calif.) raised $21 million in a series C round led by...
...$21 million in a series C round led by Bay City Capital and DT Capital. ProGenTech...